Ampio Pharmaceuticals, Inc.
AMPE
$0.0217
$0.0196933.33%
OTC PK
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.12M | 6.43M | 6.99M | 10.39M | 12.69M |
| Total Receivables | 920.00K | 530.00K | 1.38M | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | 48.00K | 18.00K | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 693.00K | 684.00K | 734.00K | 331.00K | 642.00K |
| Total Current Assets | 5.74M | 7.65M | 9.15M | 10.74M | 13.33M |
|
|
|||||
| Total Current Assets | 5.74M | 7.65M | 9.15M | 10.74M | 13.33M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | 259.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 5.74M | 7.65M | 9.15M | 10.74M | 13.59M |
|
|
|||||
| Total Accounts Payable | 750.00K | 459.00K | 627.00K | 575.00K | 97.00K |
| Total Accrued Expenses | 1.08M | 1.35M | 1.42M | 1.59M | 541.00K |
| Short-term Debt | 177.00K | -- | -- | -- | 189.00K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 274.00K | 362.00K | 354.00K | 347.00K | 340.00K |
| Total Finance Division Other Current Liabilities | 100.00K | 97.00K | 92.00K | 157.00K | 25.00K |
| Total Other Current Liabilities | 100.00K | 97.00K | 92.00K | 157.00K | 25.00K |
| Total Current Liabilities | 2.38M | 2.27M | 2.50M | 2.67M | 1.19M |
|
|
|||||
| Total Current Liabilities | 2.38M | 2.27M | 2.50M | 2.67M | 1.19M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 177.00K | -- | -- | -- | 189.00K |
| Capital Leases | -- | -- | 94.00K | 185.00K | 274.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | 333.00K |
| Total Liabilities | 2.38M | 2.27M | 2.59M | 2.86M | 1.80M |
|
|
|||||
| Common Stock & APIC | 245.89M | 245.85M | 245.80M | 245.75M | 245.73M |
| Retained Earnings | -242.53M | -240.47M | -239.24M | -237.87M | -233.94M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 3.36M | 5.38M | 6.56M | 7.88M | 11.79M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 3.36M | 5.38M | 6.56M | 7.88M | 11.79M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 3.36M | 5.38M | 6.56M | 7.88M | 11.79M |
|
|
|||||